Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

The main purpse of this study is to evaluate the safety and tolerability of KSD-101 in the treatment of relapsed or refractory EBV-associated hematological malignancies,to preliminarily explore the clinical efficacy ,evaluate the immune response to KSD-101 for the treatment in Patients with EBV-associated hematological diseases and the improvement in subjects' quality of life (QOL) after KSD-101 treatment.

Participants needed: 55
Trial details
Phase: Phase 1Age: 2-70Biological sex: AllType: InterventionalSponsor: Kousai Bio Co., Ltd.Updated: Apr 16, 2026Locations: 2
Eligibility criteria

Subjects and/or their legal guardians agree to participate and sign the ICF. [+13]

Received chemotherapy or immunosuppressive therapy within 4 weeks prior to leuka... [+18]

Status: Not yet recruiting

KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

The main purpse of this study is to evaluate the safety of KSD-101 in patients with EBV-associated Nasopharyngeal Carcinoma,to evaluate the initial clinical outcomes and evaluate the immune response to KSD-101 for the treatment in Patients with EBV-associated Nasopharyngeal Carcinoma.

Participants needed: 10
Trial details
Phase: Early Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Kousai Bio Co., Ltd.Updated: Dec 30, 2024
Eligibility criteria

Patients or their legal guardian voluntarily participate and sign an informed co... [+6]

Patients receiving any anti-tumor therapy such as chemotherapy, radiotherapy, im... [+11]